StemCells, Inc.

StemCells, Inc. is a public biopharmaceutical company headquartered in Newark, California, that is developing purified human neural stem cells (HuCNS-SCs) in the hopes of treating central nervous system disorders and paralysis. StemCells' HuCNS-SCs have the ability to differentiate into the three main types of cells found in the central nervous system: neurons, astrocytes and oligodendrocytes.[1][2]

StemCells, Inc.
TypePublic
IndustryBiotechnology
Founded1 January 1992 Edit this on Wikidata
Headquarters
Newark Edit this on Wikidata
,
United States Edit this on Wikidata
Key people
Ian Massey (CEO)
Irving L. Weissman, M.D. (Founder)
Websitewww.stemcellsinc.com

They are being studied in early stage trials.[3][4]

In March 2020, Microbot Medical Inc. announced the appointment of Eyal Morag, M.D. to Chief Medical Officer.[5]

References
  1. Falco, Miriam. (Sept. 7, 2012). "A tiny step forward for spinal cord injuries."
  2. Le Roux, Mariette. (March 5, 2014). "Science sees future beyond Paralympics."
  3. http://www.clinicaltrials.gov/ct2/show/NCT02163876
  4. "StemCells Inc says spinal injury therapy shows promise". Reuters. 2015-11-18. Retrieved 2015-12-23.
  5. "Microbot Medical Appoints Eyal Morag M.D. as Chief Medical Officer". BioSpace. Retrieved 2020-03-03.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.